ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor ForumGlobeNewsWire • 03/15/23
ResMed's Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of SleepGlobeNewsWire • 03/13/23
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare ConferenceGlobeNewsWire • 03/07/23
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair EmeritusGlobeNewsWire • 01/26/23
ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/02/23
ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software SolutionsGlobeNewsWire • 11/22/22
ResMed Opens Manufacturing Centre in Singapore, Expanding Manufacturing Footprint to Support Growth, Development, and Production of Digital Health SolutionsGlobeNewsWire • 11/16/22
ResMed: Strong Earnings Growth Supports The High Valuation, Unclear Technical TrendsSeeking Alpha • 11/14/22